General MedicationsORALGeneric
HYDROCODONE BITARTRATE AND ACETAMINOPHEN
ACETAMINOPHEN; HYDROCODONE BITARTRATE
Standard Dose
500MG/15ML;5MG/15ML
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary
Approval overview HYDROCODONE BITARTRATE AND ACETAMINOPHEN is listed in Drugs@FDA under application 089557 (ANDA).
Marketing status: Discontinued Active ingredient ACETAMINOPHEN; HYDROCODONE BITARTRATE Form and strength SOLUTION;ORAL - 500MG/15ML;5MG/15ML Sponsor MIKART Submission history Latest submission status date: 2004-07-26 00:00:00.
Structured Monograph
Clinical summary
Approval overview HYDROCODONE BITARTRATE AND ACETAMINOPHEN is listed in Drugs@FDA under application 089557 (ANDA). Marketing status: Discontinued Active ingredient ACETAMINOPHEN; HYDROCODONE BITARTRATE Form and strength SOLUTION;ORAL - 500MG/15ML;5MG/15ML Sponsor MIKART Submission history Latest submission status date: 2004-07-26 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Discontinued
Interaction Notes
- No interaction notes stored yet.